EQT Partners managing partner and CEO Thomas von Koch will be replaced by deputy managing partner and head of EQT's equity division Christian Sinding as of January 2019.
New and historical backers invest in Belgium-based Imcyse, a developer of immunotherapies
Buyout of the baking product company is the GP's fifth UK deal since opening a Manchester office
Sale ends an eight-year holding period for the GP, which owned an 83.4% stake in the company
Fresh capital will be used to develop BioSerenity's products beyond their initial focus